Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05619172 |
Title | A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | SOTIO Biotech AG |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA | ESP | BEL |